CAS: 1219184-91-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CCT 031374 hydrobromide REF: 54-BUP16146CAS: 1219184-91-4 | 98.6% | 821.00 €~2,768.00 € | Wed 16 Apr 25 |
 | CCT 031374 hydrobromide REF: TM-T21685CAS: 1219184-91-4 | 98.61% | 38.00 €~1,562.00 € | Wed 16 Apr 25 |
 | CCT 031374 hydrobromide REF: 3D-UYB18491CAS: 1219184-91-4 | Min. 95% | - - - | Discontinued product |
Ref: 54-BUP16146
| 1g | 2,768.00 € | ||
| 50mg | 821.00 € | ||
| 100mg | 1,152.00 € | ||
| 200mg | 1,403.00 € | ||
| 500mg | 2,165.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
CCT 031374 hydrobromide
CAS:1219184-91-4
CCT 031374 hydrobromide is a TCF/β-catenin inhibitor with antitumor activities.
Formula:
C23H20BrN3O
Purity:
98.61%
Color and Shape:
Solid
Molecular weight:
434.33
Ref: TM-T21685
| 1mg | 38.00 € | ||
| 5mg | 71.00 € | ||
| 10mg | 105.00 € | ||
| 25mg | 207.00 € | ||
| 50mg | 329.00 € | ||
| 100mg | 472.00 € | ||
| 200mg | 620.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
CCT 031374 hydrobromide
CAS:1219184-91-4
CCT 031374 hydrobromide is a tyrosine kinase inhibitor that inhibits the c-met receptor, which is …
Formula:
C23H19N3O·HBr
Purity:
Min. 95%
Molecular weight:
434.33 g/mol
Ref: 3D-UYB18491
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
